Founder haplotype means and 1-SDs for the three QTL mapped in both panels of DSPR RILs. by Michael A. Najarro (831657)

ARF6 knockdown increases glucosylceramide levels and decreases sphingomyelin levels in Neuro-2a cells. by Lu Li (14069)

Subjects:

Silencing of Tet3 acts to decrease mRNA expression of OxPhos and other mitochondrial-related genes in N2A cells. by Valeria Leon Kropf (17797623)

Selective downregulation of SR Ca²⁺ handling proteins and decreased SR Ca²⁺ uptake in TG mice hearts. by Mayilvahanan Shanmugam (691549)

“…<p>Equal amounts of total protein prepared from the atrial <b>(A)</b> and ventricular <b>(C)</b> tissues of one-month old TG and NTG mice were separated on SDS-PAGE and immunoprobed with specific antibodies. …”

GHD in Nestin-Cre mice leads to a decrease in STAT5 phosphorylation, lower expression of <i>Igf1</i> and an increase in the expression of <i>CD36</i> and <i>Vldlr</i> in the liver. by Jeroen Declercq (783867)

Stabilized MetA decreases the frequencies of persisters in different <i>E. coli</i> strains at elevated temperature. by Elena A. Mordukhova (646403)

Subjects:

Whole brain volume change over 5 years using the SIENA pipeline. by Renxin Chu (5169857)

Tg2576 mice treated with OG showed markedly increased α-secretase cleavage of APP and significantly decreased levels of Aβ generation. by She-Qing Zhang (446556)

FK866 treatment causes a time dependent decrease in cellular NAD⁺/NADH and NADP⁺/NADPH content. by Gerda Venter (559404)

Descriptive statistics (mean [standard deviation] or % [sample size]) for study variables analyzed in the current study. by Angelina R. Sutin (9216456)

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice treated with 0.5% bupivacaine (BUP) combined with topical (TOP) application, following subconjunctival injection (SCI) of CGRP, 24 hours before the final BUP treatment (day 14) and again one hour prior to the final bupivacaine injection on day 15. by Ananya Datta (19932144)

Decreased NR1 and NR2A protein expression in 21-day group. by Chenxia Han (4020017)

“…The levels of both the NR1 <b>(A)</b> and NR2A <b>(B)</b> proteins of the 21-day group decreased compared with the control group, and the other two groups as well.…”

D257A mice display decreased mRNA expression of nuclear genes encoding components of ETC Complexes I, III and IV. by Asimina Hiona (246175)

Disruption of <i>hbhA</i> decreases apoptosis and ΔΨ_m dissipation in macrophages infected with <i>M. tuberculosis</i>. by Hosung Sohn (193388)

Microinjection of morphine in rat rostromedial tegmental nucleus (RMTg) decreased non-rapid eye movement (NREM) sleep in a dose-dependent manner. by Su-Rong Yang (467756)

Cyclin D1 and cyclin E expression were significantly decreased in A549 cells with knocked down p120ctn. by Guiyang Jiang (164288)

“…<p>(<b>A</b>) The results of western blot analysis showed that proteins cyclin D1 (*, <i>p</i> = 0.001) and cyclin E (*, <i>p</i> = 0.004) were significantly decreased after p120ctn was knocked down in A549 cells. …”

Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

“…Data are shown as mean ± SEM. Created in BioRender. Vignozzi, L. (2025) <a href="https://BioRender.com/md8zh2c" target="_blank">https://BioRender.com/md8zh2c</a>. …”

Induction of duodenal and hepatic Cyps in VD₃ deficient mice after DEX treatment. by Kavya Annu (11587215)

Subjects:

Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study by Jon Jarløv Rasmussen (2993427)

“…</p><p>Methods</p><p>This study had a cross-sectional case-control design and involved 37 current AAS abusers, 33 former AAS abusers (mean (95%CI) elapsed duration since AAS cessation: 2.5 (1.7; 3.7) years) and 30 healthy control participants. …”

Decreased 11ß-HSD1 protein level by IGF-I overexpression <i>in vivo</i> and a direct treatment with IGF-I. by Subrata Chowdhury (787208)

“…<p><b>A</b>. IGF-I overexpression decreased the levels of 11ß-HSD1 in pancreatic islets, liver and visceral fat, shown in Western blots. …”